... with cervical cancer, 36.1 ± 9.4 among women with premalignant lesions, and 36.6 ± 11.5 in healthy individuals. In total, 290 out of 364 samples were human papillomavirus (HPV) positive and the following HPV genotypes were detected among them: HPV 16/18 was found in 43.1%, 23.9%, and 65.5% of normal...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Human papillomavirus Genotypes Bivalent vaccine Zimbabwe Human papillomaviruses (HPVs) are double...

...Xiaoyan Rao; Jie Jiang; Yifeng Wang; Xueli Ma; Shuxia Liu Introduction: Cervical cancer (CC) is a prevailing malignant tumor in women, mainly caused by human papillomavirus (HPV) infection. This study investigated miR-106a expression in the serum of HPV-positive CC patients and estimated its value...

...Ishita Gupta; Reem Al-Sarraf; Hanan Farghaly; Semir Vranic; Ali A. Sultan; Hamda Al-Thawadi; Ala-Eddin Al Moustafa; Halema F. Al-Farsi Introduction: Human papillomaviruses (HPVs), Epstein-Barr virus (EBV), and mouse mammary tumor virus-like virus (MMTV-like virus) can be present and contribute...

...Natalia Kisseljova; Kirill Zhordania; Maria Fedorova; Alexey Katargin; Adelina Valeeva; Julia Pajanidi; Larisa Pavlova; Olga Khvan; Svetlana Vinokurova Background/Aims: High-risk human papillomavirus (HPV) infection is associated with different malignancies, but its role in the pathogenesis...

...Zabihollah Shoja; Mohammad Farahmand; Neda Hosseini; Somayeh Jalilvand Introduction: To date, the human papillomavirus (HPV) vaccine has not been integrated into the national vaccination program of most countries of the WHO Eastern Mediterranean Region (EMRO), except for the United Arab Emirates...

...Aleksandra Pesic; Amrei Krings; Carola Schreckenberger; Matthias Hempel; Rosemarie Preyer; Andreas M. Kaufmann Background: Cervical cancer is caused by a persistent infection of human papillomavirus (HPV). Therefore, tests which detect the carcinogenic virus can be used for cervical cancer...

...Takudzwa Marembo; Racheal Dube Mandishora; Margaret Borok Background/Aims: In Zimbabwe, cervical cancer is screened through cytology and visual inspection with acetic acid and cervicography (VIAC). The effectiveness of these methods can be increased if complemented by a human papillomavirus DNA...

...Pornjarim Nilyanimit; Jira Chansaenroj; Jatupol Srisomboon; Wanida Rodrangnok; Ngamta Rajakom; Ekkachai Daengsaard; Nutthavit Sookrak; Yong Poovorawan Objective: Anogenital warts are caused by human papillomavirus (HPV). Globally, HPV genotypes 6 and 11 are most often associated with anogenital...

.... Human papillomavirus Cervical cancer Promoter methylation HPV E1 Cervical cancer is the second most common gynaecological cancer worldwide [ 1 ], with more than 90% of cases caused by human papillomaviruses (HPV). Although there are over 150 types of HPV, HPV16 is the major etiological agent...

...Eskandar Taghizadeh; Forough Taheri; Hamed Abdolkarimi; Pedram Ghorbani Renani; Seyed Mohammad Gheibi Hayat Objective: Cervical cancer is the third most common malignancy in females. Since the human papillomavirus (HPV) genotype can vary geographically, it is essential to define its genotypic...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Human papillomavirus genotyping Human papillomavirus Anal cancer screening Self-sampling High-risk human papillomavirus types Human papillomaviruses (HPV) with oncogenic potential, mainly...

...Zhenping Shen; Xia Liu; Janice Morihara; Ayaka Hulbert; Laura A. Koutsky; Nancy B. Kiviat; Long Fu Xi Objective: To explore the possibility of single-cell analysis of human papillomavirus (HPV) infection. Methods: Two hundred and twenty cells were isolated by laser capture microdissection from...

...Isaías Badillo-Almaraz; Pablo Zapata-Benavides; Santiago Saavedra-Alonso; Diana Zamora-Avila; Diana Reséndez-Pérez; Reyes Tamez-Guerra; Rafael Herrera-Esparza; Cristina Rodríguez-Padilla Background/Aims: Human papillomavirus (HPV) is an epitheliotropic, double-stranded DNA virus, and its high-risk...

...Rui Zhang; Jie Huang; Pu Wang; Yu Sun; Kuo Zhang; Jiehong Xie; Shangxian Gao; Lunan Wang; Jinming Li Background: In China, various assays for human papillomavirus (HPV) genotyping are currently used for cervical cancer screening. However, a proficiency test system is not available for standardizing...

...Shoufang Qu; Jie Huang; Jinyin Zhao; Xuequan Zhao; Haijun Deng; Huawei Yang; Weijun Chen; Licheng Liu; Lining Zhang; Shangxian Gao Background: Human papillomavirus (HPV) testing coupled with appropriate clinical management is associated with a significant decline in the rate of advanced cervical...

... Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 90: Human Papillomaviruses. Lyon, IARC, 2007. 4 Camara GNL, Cerqueira DM, Oliveira APG, Silva EO, Carvalho LGS, Martins CRF: Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal...

...Maria Antonia De Francesco; Franco Gargiulo; Claudio Schreiber; Giuseppe Ciravolo; Federica Salinaro; Nino Manca Objectives: The aim of this study was to determine both human papillomavirus (HPV) prevalence and type distribution in cervical specimens of women with cytological abnormalities...

...Pierpaolo Paba; Daniela Bonifacio; Luigi Di Bonito; Domenico Ombres; Cartesio Favalli; Kari Syrjänen; Marco Ciotti Objective: Oncogenic human papillomaviruses (HPVs) are the etiological agents of cervical cancer. Different cofactors might be needed for malignant transformation, but they still...

... groups (progressive, persistent, and regressive disease) according to the results. The human papillomavirus (HPV) genome and viral types were identified by Southern blot hybridization at T m -40° and T m -20° with DNA extracted from exfoliated cervical cells. The lesion progressed to CIN III in 4/87...